Phyllosilicate adsorption limited phosphorus bioavailability in early ferruginous oceans
Xing Cui1, Zongbin Zhang2, Qin Li3
1Department of Earth and Planetary Sciences, The University of Hong Kong, Pokfulam Road, Hong Kong, China.
Nature Communications
|February 6, 2026
Summary
Early Earth
Area of Science:
- Geochemistry
- Biogeochemistry
- Early Earth Science
Background:
- The phosphorus (P) cycle is crucial for life's evolution, linking Earth's biosphere and geosphere.
- Modern P availability depends on mineral adsorption, but early Earth's anoxic conditions present unknowns.
- Understanding early P cycling is key to understanding the origin and evolution of early life.
Purpose of the Study:
- To investigate the role of phyllosilicates in the early phosphorus (P) cycle.
- To evaluate P adsorption onto phyllosilicates under early Earth's anoxic, ferruginous conditions.
Main Methods:
- Experimental investigations of P adsorption onto phyllosilicates.
- Theoretical modeling of P adsorption processes.
- Analysis of P adsorption in simulated early Earth's ferruginous waters.
Main Results:
- Phosphorus adsorption onto phyllosilicates was significantly enhanced in early ferruginous waters.
- Dissolved Fe(II) acted as a bridge, enhancing P adsorption.
- Enhanced adsorption facilitated P transport during weathering but also promoted burial in marine settings.
Conclusions:
- Phyllosilicate adsorption influenced P availability in early Earth's oceans.
- This process limited dissolved P release during seafloor weathering.
- Collectively, these processes may have constrained P availability for early life's origin and evolution.
Related Concept Videos
The Phosphorus Cycle
44.0K
Unlike carbon, water, and nitrogen, phosphorus is not present in the atmosphere as a gas. Instead, most phosphorus in the ecosystem exists as compounds, such as phosphate ions (PO43-), found in soil, water, sediment and rocks. Phosphorus is often a limiting nutrient (i.e., in short supply). Consequently, phosphorus is added to most agricultural fertilizers, which can cause environmental problems related to runoff in aquatic ecosystems.
44.0K
Limiting Reactant
70.2K
The relative amounts of reactants and products represented in a balanced chemical equation are often referred to as stoichiometric amounts. However, in reality, the reactants are not always present in the stoichiometric amounts indicated by the balanced equation.
70.2K
Analyte Adsorption and Distribution
2.8K
In certain chromatographic separations, solutes transfer between the mobile phase and the stationary phase via sorption, which typically refers to the process of adsorption. For many chromatographic systems, the sorption process often depends on the polarity of the compounds—an expression of the overall dipole moment within the molecule. During the separation process, there is competition between the solute and solvent for adsorption to the stationary phase. Highly polar compounds and...
2.8K
Bioavailability: Overview
452
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
452
Bioavailability: Overview
4.5K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
4.5K
Bioavailability Study Design: Absolute Versus Relative Bioavailability
365
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
365


